Evidence map›Paper›PMID 27698062›Full record

ArticleHypertension (Dallas, Tex. : 1979)2016

Agonistic Autoantibodies to the Angiotensin II Type 1 Receptor Enhance Angiotensin II-Induced Renal Vascular Sensitivity and Reduce Renal Function During Pregnancy.

Mark W Cunningham, Jan M Williams, Lorena Amaral, Nathan Usry, Gerd Wallukat, Ralf Dechend, Babbette LaMarca

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 56 citations in OpenAlex.

  1. Increased ATCell death & disease · 2020
    Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. AT1-AA Infusion during Pregnancy Impairs CBF Autoregulation Postpartum.International journal of cerebrovascular disease and stroke · 2023
    Article
  11. Inhibition of the ATAmerican journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Advances in biomarker development and potential application for preeclampsia based on pathogenesis.European journal of obstetrics & gynecology and reproductive biology: X · 2021
    Review
  19. Article
  20. Local angiotensin-(1-7) administration improves microvascular endothelial function in women who have had preeclampsia.American journal of physiology. Regulatory, integrative and comparative physiology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mark W CunninghamFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Jan M WilliamsFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Lorena AmaralFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Nathan UsryFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Gerd WallukatFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Ralf DechendFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.).
Babbette LaMarcaFrom the Departments of Pharmacology and Toxicology (M.W.C., J.M.W., L.A., N.U., B.L.M.) and Obstetrics and Gynecology (B.L.M.), University of Mississippi Medical Center, Jackson; Experimental and Clinical Research Center, Charité Campus Buch, Max-Delbrück Center for Molecular Medicine, Berlin, Germany (G.W.); and Experimental and Clinical Research Center, HELIOS Clinic, Berlin, Germany (R.D.). bblamarca@umc.edu.
Max Delbrück Center · DE

Funding

STRUCTURAL VASCULAR ADAPTATION OF THE MICROCIRCULATIONP01HL051971 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI RECKELHOFF, JANE F · 1993 to 2018
$39.4M
The role of leptin in autoimmune-associated hypertensionP20GM104357 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI HALL, JOHN E · 2013 to 2022
$23.4M
Hypertension and Cardiorenal Research Training ProgramT32HL105324 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI Joey P. Granger · 2010 to 2026
$7.8M
The Kidney, Hypertension, Pregnancy and InflammationR01HD067541 · NICHD · UNIVERSITY OF MISSISSIPPI MED CTR · PI LAMARCA, BABBETTE · 2011 to 2020
$3.1M
Hypertension, Kidney and PregnancyR01HL108618 · NHLBI · UNIVERSITY OF MISSISSIPPI MED CTR · PI GRANGER, JOEY P. · 2011 to 2015
$1.8M
Mechanisms of Pregnancy Induced HypertensionF32HL078147 · NHLBI · UNIVERSITY OF MISSISSIPPI MEDICAL CENTER · PI LAMARCA, BABBETTE · 2005 to 2007
$149k
NHLBI NIH HHS F32 HL078147NHLBI NIH HHS P01 HL051971NHLBI NIH HHS R01 HL108618NHLBI NIH HHS T32 HL105324NICHD NIH HHS R01 HD067541NIGMS NIH HHS P20 GM104357
6 · The paper itself

Abstract

Preeclamptic women produce agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA) and exhibit increased blood pressure (mean arterial pressure), vascular sensitivity to angiotensin II (ANG II), and display a decrease in renal function. The objective of this study was to examine the renal hemodynamic changes during pregnancy in the presence of AT1-AAs with or without a slow pressor dose of ANG II. In this study, mean arterial pressure was elevated in all pregnant rats treated with ANG II with or without AT1-AA. Glomerular filtration rate was reduced from 1.90±0.16 mL/min in normal pregnant (NP) to 1.20±0.08 in ANG II+AT1-AA rats. Renal blood flow was decreased in ANG II+AT1-AA versus NP rats to 7.4±1.09 versus 15.4±1.75 mL/min. Renal vascular resistance was drastically increased between ANG II+AT1-AA versus NP rats (18.4±2.91 versus 6.4±0.77 mm Hg/mL per minute). Isoprostane excretion was increased by 3.5-fold in ANG II+AT1-AA versus NP (1160±321 versus 323±52 pg/mL). In conclusion, ANG II and AT1-AA together significantly decrease glomerular filtration rate by 37% and renal blood flow by 50% and caused a 3-fold increase in renal vascular resistance and isoprostane levels versus NP rats. These data indicate the importance of AT1-AAs to enhance ANG II-induced renal vasoconstriction and reduce renal function as mechanisms to cause hypertension as observed during preeclampsia.

Indexed as

Pregnancy, AnimalAnalysis of VarianceAngiotensin IIAngiotensin II Type 1 Receptor BlockersAnimalsAutoantibodiesFemaleGlomerular Filtration RateHumansHypertension, Pregnancy-InducedKidney Function TestsOxidative StressPlacental CirculationPregnancyPregnancy OutcomeRatsAngiotensin IIAngiotensin II Type 1 Receptor BlockersAutoantibodiesReceptor, Angiotensin, Type 1angiotensin IIautoantibodieshypertensionpreeclampsiapregnancy

Identifiers

PMID27698062
PMCPMC5142826
OpenAlexW2531225451

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.